GSK announces EMA accepted for review MAA for depemokimab
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...
Bearish flow noted in GSK (GSK) Pharma with 1,694 puts trading, or 4x expected. Most active are 2/7 weekly 34 puts and Jan-27 28 puts, with total volume in those strikes near 1,600 contracts. The ...
Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.
The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...
GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and ...
Check the time stamp on this data. Updated AI-Generated Signals for Gsk Plc American Depositary Shares (each Representing Two ...
Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...
GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...
Shares of GSK PLC GSK inched up 0.59% to £13.64 Thursday, on what proved to be an all-around positive trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback